Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Xpovio

(ex-POH-vee-oh)
A drug used alone or with other drugs to treat adults with certain types of diffuse large B-cell lymphoma or multiple myeloma. It is used in patients whose cancer has already been treated with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Xpovio blocks a protein called CRM1, which may help keep cancer cells from growing and may kill them. It is a type of small molecule inhibitor. Also called selinexor.
More Information
Search NCI's Dictionary of Cancer Terms